Testing effectiveness (Phase 2)Study completedNCT00389441What this trial is testingStudy Of AG-013736 In Patients With 131I-Refractory Thyroid CancerWho this might be right forThyroid Neoplasms Pfizer 52
Testing effectiveness (Phase 2)Study completedNCT01164176What this trial is testingEverolimus in Treating Patients With Locally Advanced or Metastatic Thyroid CancerWho this might be right forHead and Neck Cancer Yonsei University 40
Testing effectiveness (Phase 2)Study completedNCT00537095What this trial is testingEfficacy and Safety of Vandetanib (ZD6474) in Patients With Metastatic Papillary or Follicular Thyroid CancerWho this might be right forThyroid Neoplasms Genzyme, a Sanofi Company 164
Testing effectiveness (Phase 2)Looking for participantsNCT06959641What this trial is testingXL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid CancerWho this might be right forLocally Advanced Differentiated Thyroid Gland CarcinomaLocally Advanced Poorly Differentiated Thyroid Gland CarcinomaLocally Advanced Thyroid Gland Follicular Carcinoma+18 more Northwestern University 33
Testing effectiveness (Phase 2)Study completedNCT00134043What this trial is testingSuberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid CancerWho this might be right forInsular Thyroid CancerRecurrent Thyroid CancerStage II Follicular Thyroid Cancer+4 more National Cancer Institute (NCI) 19
Early research (Phase 1)Study completedNCT00005647What this trial is testingSU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and NeckWho this might be right forHead and Neck Cancer Case Comprehensive Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT00095836What this trial is testingGefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine TherapyWho this might be right forHead and Neck Cancer Massachusetts General Hospital 27
Testing effectiveness (Phase 2)Ended earlyNCT00095693What this trial is testingSorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid CancerWho this might be right forAnaplastic Thyroid CancerInsular Thyroid CancerRecurrent Thyroid Cancer+4 more National Cancer Institute (NCI) 25
Testing effectiveness (Phase 2)Study completedNCT00121628What this trial is testingA Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid CancerWho this might be right forThyroid Cancer Amgen 184